299 related articles for article (PubMed ID: 11254711)
1. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
Haque MA; Hawes JW; Blum JS
J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
[TBL] [Abstract][Full Text] [Related]
2. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
3. Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells.
Dong X; An B; Salvucci Kierstead L; Storkus WJ; Amoscato AA; Salter RD
J Immunol; 2000 Jan; 164(1):129-35. PubMed ID: 10605003
[TBL] [Abstract][Full Text] [Related]
4. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
5. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.
Sinnathamby G; Eisenlohr LC
J Immunol; 2003 Apr; 170(7):3504-13. PubMed ID: 12646611
[TBL] [Abstract][Full Text] [Related]
6. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
[TBL] [Abstract][Full Text] [Related]
7. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90).
Kang HK; Mikszta JA; Deng H; Sercarz EE; Jensen PE; Kim BS
J Immunol; 2000 Feb; 164(4):1775-82. PubMed ID: 10657624
[TBL] [Abstract][Full Text] [Related]
8. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
Snyder CM; Zhang X; Wysocki LJ
J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
[TBL] [Abstract][Full Text] [Related]
9. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
[TBL] [Abstract][Full Text] [Related]
11. Inefficient peptide binding by cell-surface class II MHC molecules.
Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE
Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804
[TBL] [Abstract][Full Text] [Related]
12. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
Pathak SS; Blum JS
Traffic; 2000 Jul; 1(7):561-9. PubMed ID: 11208144
[TBL] [Abstract][Full Text] [Related]
13. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
[TBL] [Abstract][Full Text] [Related]
14. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
[TBL] [Abstract][Full Text] [Related]
15. Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cells.
Marsh EW; Dalke DP; Pierce SK
J Exp Med; 1992 Feb; 175(2):425-36. PubMed ID: 1310101
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.
Qi L; Rojas JM; Ostrand-Rosenberg S
J Immunol; 2000 Nov; 165(10):5451-61. PubMed ID: 11067897
[TBL] [Abstract][Full Text] [Related]
17. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis.
Huang JC; Han M; Minguela A; Pastor S; Qadri A; Ward ES
J Immunol; 2003 Sep; 171(5):2467-77. PubMed ID: 12928395
[TBL] [Abstract][Full Text] [Related]
18. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
19. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
20. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
